Pharmaceuticals News
News Headlines |
Regional News |
Industry News | Prominent People:
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
Pharmaceuticals News
Forbes Earnings Preview: WatsonLeading up to Watson Pharmaceuticals' (WPI) announcement of its fourth quarter earnings on Tuesday, February 14, 2012, analysts have become more bullish as expectations have improved over the past month from $1.61 per share to the current projection of earnings of $1.75 per share.
Posted on 9 February 2012 | 7:58 pm
Watson Pharmaceuticals Inc. Fourth QuarterHere's what you need to know for the upcoming earnings release ...
Posted on 9 February 2012 | 7:20 pm
Synergy Pharmaceuticals to Present at 14thSynergy Pharmaceuticals, Inc. , a developer of new drugs to treat gastrointestinal disorders and diseases, today announced that its President and CEO, Gary S. Jacob, Ph.D, will present at the 14th Annual BIO CEO & Investor Conference.
Posted on 9 February 2012 | 1:00 pm
Auxilium Pharmaceuticals to Announce FourthMALVERN, Pa., Feb. 9, 2012 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL - News), a specialty biopharmaceutical company, will release results for the fourth quarter 2011 on Thursday, February 23, ...
Posted on 9 February 2012 | 12:00 pm
Ironwood Pharmaceuticals Announces ProposedIronwood Pharmaceuticals, Inc. announced today that it has commenced an underwritten public offering of 5,250,000 shares of its Class A common stock. All of the shares are being offered by Ironwood.
Posted on 8 February 2012 | 9:57 pm
Pharmaceuticals News
Forbes Earnings Preview: WatsonLeading up to Watson Pharmaceuticals‘ (WPI) announcement of its fourth quarter earnings on Tuesday, February 14, 2012, analysts have become more bullish as expectations have improved over the past month from $1.61 per share to the current ...
Posted on 9 February 2012 | 7:49 pm
Product and Project Updates Sent These SmallHence, why the company only has $2k in cash on hand needs some explaining. Elite Pharmaceuticals (OTC: ELTP) Elite Pharmaceuticals develops oral sustained and controlled release products. On Tuesday, Elite Pharmaceuticals announced the initial shipment of ...
Posted on 9 February 2012 | 6:45 pm
Dava Pharmaceuticals agrees to $11MThe Justice Department said Wednesday that a New Jersey-based Dava Pharmaceuticals Inc. has agreed to pay the U.S. $11 million to settle allegations on misreporting drug prices. The government said Wednesday that Dava agreed to the settlement over charges ...
Posted on 9 February 2012 | 3:32 pm
Savient Pharmaceuticals to Present at theEAST BRUNSWICK, N.J., Feb. 8, 2012 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (NASDAQ: SVNT - News) today announced that Kenneth Zuerblis, Executive Vice President and Chief Financial Officer of Savient will present at the Leerink Swann 2012 ...
Posted on 9 February 2012 | 11:00 am
Dava Pharmaceuticals agrees to pay $11M toWASHINGTON — The Justice Department says that a New Jersey-based pharmaceuticals company has agreed to pay the U.S. $11 million to settle allegations on misreporting drug prices. The government said Wednesday that Dava Pharmaceuticals Inc. agreed to the ...
Posted on 8 February 2012 | 10:28 pm











